En pionjär inom detektion och prevention inom dermatologi.

Mission

Vi stärker hälso- och sjukvårdspersonal inom dermatologi genom att tillhandahålla vetenskapsbaserade, innovativa lösningar för prediktion, diagnostik och sjukdomsövervakning.

Vår unika plattform - som kombinerar vår banbrytande teknik EIS med artificiell intelligens - möjliggör tidig upptäckt av hudcancer och stöttar dermatologer att på bästa sätt kunna optimera vården inom en rad olika hudsjukdomar.

Ökad nettoomsättning
53%
2022
Melanom-marknadens potential
SEK >3.0 BN
Approved
72
patents
Bruttomarginal
62.8%
2022

Produktportfolio

Nevisense
Nevisense Go Platform
Engångselektroder
Nevisense Instrumentpanel

Precision and Accuracy

Skin tissue has electrical properties that are affected by certain medical conditions. To measure the skins electrical impedance makes it possible to detect changes in the skin that can indicate certain diseases, such as melanoma. SciBase Nevisense system utilizes a technology called Electrical Impedance Spectroscopy (EIS) to analyze the electrical properties of the skin. This technology involves the application of a small electrical current to the skin's surface through the proprietary Nevisense electrodes. The changes in these currents as they pass through the tissue are analysed immediately after the measurement by AI-based classification algorithms to evaluate the skin or classify the risk level of the lesion. Through this the Nevisense system can detect subtle changes or abnormalities that may not be visible to the naked eye.